Antimicrobial susceptibility of Staphylococcus pseudintermedius isolated from the cutaneous bacterial infections in dogs to cefovecin sodium (Convenia®), Japan, 2008–2018
Satoshi Matsumoto, Do-Ho Bae, R. Uemura, N. Misawa, Kota Ishii, Yoriko Hashiguchi, M. Iwahana, Subaru Fujiwara, K. Nishifuji
{"title":"Antimicrobial susceptibility of Staphylococcus pseudintermedius isolated from the cutaneous bacterial infections in dogs to cefovecin sodium (Convenia®), Japan, 2008–2018","authors":"Satoshi Matsumoto, Do-Ho Bae, R. Uemura, N. Misawa, Kota Ishii, Yoriko Hashiguchi, M. Iwahana, Subaru Fujiwara, K. Nishifuji","doi":"10.2736/jjvd.27.85","DOIUrl":null,"url":null,"abstract":": The in vitro susceptibility of Staphylococcus pseudintermedius to cefovecin sodium (CFV) was investigated using isolates obtained from dogs with suspected bacterial skin infection between 2008 and 2018. Bacterial species were identified. The resistance rates of S. pseudintermedius increased approximately five times from 2008 to 2014 but remained around 20% after 2014. The results highlight the importance of continued monitoring and education in the use of CFV to minimize drug resistance.","PeriodicalId":22603,"journal":{"name":"The Japanese Journal of Veterinary Dermatology","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese Journal of Veterinary Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2736/jjvd.27.85","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
: The in vitro susceptibility of Staphylococcus pseudintermedius to cefovecin sodium (CFV) was investigated using isolates obtained from dogs with suspected bacterial skin infection between 2008 and 2018. Bacterial species were identified. The resistance rates of S. pseudintermedius increased approximately five times from 2008 to 2014 but remained around 20% after 2014. The results highlight the importance of continued monitoring and education in the use of CFV to minimize drug resistance.